This is a prospective non-randomized clinical trial to evaluate the feasibility of 3 fraction versus a standard 4 fraction high dose rate brachytherapy regimen in patients with locally advanced cervical cancer.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-06.